{"id":"CHEMBL1088324","canonicalSmiles":"O=C(O)CCP(=O)(O)O","inchiKey":"NLBSQHGCGGFVJW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1088324","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03379"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL109747","canonicalSmiles":"CCCCCCCCCCCCCC[N+](C)(C)C.[Cl-]","inchiKey":"CEYYIKYYFSTQRU-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETHYL-TETRADECYL-AMMONIUM CHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1180003","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trimethyl-tetradecyl-ammonium chloride"],"crossReferences":{"PubChem":["144211225"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL116675","canonicalSmiles":"OCC(F)(F)F","inchiKey":"RHQDFWAXVIIEBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIFLUOROETHANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,2,2-Trifluoro-Ethanol","2,2,2-Trifluoroethanol"],"crossReferences":{"PubChem":["144208103"],"Wikipedia":["2,2,2-Trifluoroethanol"],"drugbank":["DB03226"],"chEBI":["42330"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1170047","canonicalSmiles":"NC(=O)c1ccc(I)c([N+](=O)[O-])c1","inchiKey":"MDOJTZQKHMAPBK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INIPARIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BSI-201","Iniparib"],"crossReferences":{"PubChem":["137275940"],"Wikipedia":["Iniparib"],"drugbank":["DB13877"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1185001","canonicalSmiles":"CNC(=O)[C@@H]1Cc2ccc(NS(=O)(=O)O)cc2CN1C(=O)OCc1ccccc1","inchiKey":"MFDBNNQUDZFSES-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1185001","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08549"]},"childChemblIds":["CHEMBL383033"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL119604","canonicalSmiles":"OCCNCCO","inchiKey":"ZBCBWPMODOFKDW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIETHANOLAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diethanolamine","Diolamine","NSC-4959"],"crossReferences":{"PubChem":["144208899","144210354","17389594","49679190"],"Wikipedia":["Diethanolamine"],"chEBI":["28123"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1198147","canonicalSmiles":"N=C(N)c1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CCc2ccccc2)cc1","inchiKey":"RNZKCCPFUWHBFY-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1198147","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06942"]},"childChemblIds":["CHEMBL597201","CHEMBL3423007"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200405","canonicalSmiles":"CS(=O)(=O)O.Cc1ccc(C(=O)Oc2ccc(C(O)CNC(C)(C)C)cc2OC(=O)c2ccc(C)cc2)cc1","inchiKey":"HODFCFXCOMKRCG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BITOLTEROL MESYLATE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201295","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tomalate","Tornalate"],"synonyms":["Bitolterol mesilate","Bitolterol mesylate","WIN 32,784","WIN-32784"],"crossReferences":{"chEBI":["3134"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984."}
{"id":"CHEMBL1200512","canonicalSmiles":"CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC.Cl.O","inchiKey":"OHNBIIZWIUBGTK-NYPSMHOZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IRINOTECAN HYDROCHLORIDE HYDRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL481","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Campto","Camptosar","Irinotecan HCl"],"synonyms":["U-101440E"],"crossReferences":{"PubChem":["49681552"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200623","canonicalSmiles":"CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"AOXRBFRFYPMWLR-XGXHKTLJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYLESTRENOL","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Maxibolin"],"synonyms":["Ethylestrenol","Ethylnandrol","Ethyloestrenol"],"crossReferences":{"PubChem":["144206065","170465211","50112767"],"Wikipedia":["Ethylestrenol"],"drugbank":["DB01493"],"chEBI":["31578"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1964."}
{"id":"CHEMBL1200809","canonicalSmiles":"CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1.Cl","inchiKey":"YEJAJYAHJQIWNU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZELASTINE HYDROCHLORIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL639","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Astelin","Astepro","Azelastine hydrochloride","Optilast","Optivar","Rhinolast","Rhinolast allergy"],"synonyms":["A-5610","Azelastine hydrochloride","E-0659","W-2979M"],"crossReferences":{"DailyMed":["azelastine%20hydrochloride"],"PubChem":["144205022","170465172","26749052","49681818"],"chEBI":["2951"]},"count":5,"approvedIndications":["EFO_0005854","EFO_0007533","EFO_0007141","EFO_0003956"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0009364","EFO_0007533","EFO_0007141","EFO_1001417","EFO_0003956"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 4 approved and 1 investigational indication."}
{"id":"CHEMBL1200820","canonicalSmiles":"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H](C(=O)[O-])C(C)(C)S[C@H]23)c2ccccc2)C(=O)C1=O.[Na+]","inchiKey":"WCMIIGXFCMNQDS-IDYPWDAWSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPERACILLIN SODIUM","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL702","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Isipen","Pentacillin","Piperacil","Piperacillin","Pipracil","Pipril"],"synonyms":["CL 227,193","CL-227193","Piperacillin","Piperacillin sodium","Piperacillin sodium salt","T-1220"],"crossReferences":{"DailyMed":["piperacillin%20sodium"],"PubChem":["855886"],"chEBI":["8233"]},"count":9,"approvedIndications":["EFO_0003106","EFO_0007149","EFO_1001388","EFO_0008588","EFO_1001459","EFO_0003035","EFO_1001312"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 7 approved and 2 investigational indications."}
{"id":"CHEMBL1200873","canonicalSmiles":"CS(=O)(=O)O.Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1","inchiKey":"OGIYDFVHFQEFKQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENTOLAMINE MESYLATE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL597","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oraverse","Phentolamine mesylate","Regitine","Rogitine"],"synonyms":["NV-101","Phentolamine mesilate","Phentolamine mesylate","Phentolamine methanesulfonate"],"crossReferences":{"DailyMed":["phentolamine%20mesylate"],"PubChem":["11112076","50106870","56423107","85231326","855630"]},"count":2,"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["EFO_0000319","MONDO_0008315"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and has 2 investigational indications."}
{"id":"CHEMBL1200874","canonicalSmiles":"CCCCNC(=O)[N-]S(=O)(=O)c1ccc(C)cc1.[Na+]","inchiKey":"QKHDBRQBSNZFAK-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLBUTAMIDE SODIUM, STERILE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL782","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Orinase diagnostic"],"synonyms":["Tolbutamide sodium","Tolbutamide sodium, sterile"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961."}
{"id":"CHEMBL1200896","canonicalSmiles":"CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\\CCCC(=O)O.NC(CO)(CO)CO","inchiKey":"IYGXEHDCSOYNKY-RZHHZEQLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DINOPROST TROMETHAMINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL815","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dinoprost Trometamol","Lutalyse","PGF2A","Prostaglandin F 2 Alpha","Prostin f2 alpha"],"synonyms":["Dinoprost trometamol","Dinoprost tromethamine","PGF2ALPHA THAM","U-14,583E","U-14583E"],"crossReferences":{"PubChem":["11532973"],"drugbank":["DB01160"],"chEBI":["31502"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200970","canonicalSmiles":"CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21.Cl","inchiKey":"VXPCQISYVPFYRK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHOPROPAZINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1206","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Parsidol"],"synonyms":["Ethopropazine hydrochloride","Profenamine","Profenamine hibenzate","Profenamine hydrochloride","Prophenamine hydrochloride"],"crossReferences":{"PubChem":["144204047","170465065","26748043","26748044"],"chEBI":["31568"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201154","canonicalSmiles":"CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1.O=S(=O)(O)CCS(=O)(=O)O","inchiKey":"SWOUGRBFXFILIB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROCHLORPERAZINE EDISYLATE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL728","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Compazine","Prochlorperazine edisylate"],"synonyms":["Prochlorperazine edisylate","Prochlorperazine ethanedisulfonate"],"crossReferences":{"DailyMed":["prochlorperazine%20edisylate"],"PubChem":["26748222","56422461"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201187","canonicalSmiles":"Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1","inchiKey":"GSNHKUDZZFZSJB-QYOOZWMWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MARAVIROC","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Celsentri","Selzentry"],"synonyms":["Maraviroc","Rel-Maraviroc","UK-427857"],"crossReferences":{"DailyMed":["maraviroc"],"Wikipedia":["Maraviroc"],"drugbank":["DB04835"],"chEBI":["63608"]},"childChemblIds":["CHEMBL4476214","CHEMBL4586236"],"count":16,"approvedIndications":["EFO_0000764","EFO_0000180","EFO_0000763"],"linkedTargets":{"rows":["ENSG00000160791"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","MONDO_0013730","EFO_0000685","EFO_0000765","EFO_0000180","EFO_0000403","EFO_1001461","MONDO_0044881","EFO_0004211","EFO_0002608","EFO_1001480","MONDO_0100096","EFO_0000339","EFO_0000544","EFO_0000095","EFO_0000764","EFO_0000712","MONDO_0018906","EFO_0000183","EFO_0000763"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 3 approved and 13 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201213","canonicalSmiles":"CCC(NC(C)C)C(O)c1ccc(O)c(O)c1","inchiKey":"HUYWAWARQUIQLE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOETHARINE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Etyprenaline","Isoetarine","Isoetharine","WIN 3406","WIN-3406"],"crossReferences":{"PubChem":["90341304"],"Wikipedia":["Isoetarine"],"drugbank":["DB00221"],"chEBI":["6005"]},"childChemblIds":["CHEMBL1200920","CHEMBL1201153"],"count":1,"approvedIndications":["HP_0006536"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["HP_0006536"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979 and is indicated for airway obstruction."}
{"id":"CHEMBL1201288","canonicalSmiles":"O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1","inchiKey":"OZOMQRBLCMDCEG-VIZOYTHASA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DANTROLENE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dantrolene","F-368"],"crossReferences":{"DailyMed":["dantrolene%20sodium"],"PubChem":["26756482","26756773"],"TG-GATEs":["119"],"Wikipedia":["Dantrolene"],"drugbank":["DB01219"]},"childChemblIds":["CHEMBL2067986","CHEMBL928"],"count":4,"linkedTargets":{"rows":["ENSG00000198838","ENSG00000196218"],"count":2},"linkedDiseases":{"rows":["EFO_1001340","EFO_0000546","EFO_0003885","EFO_0005306","HP_0001945","Orphanet_3463"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201516","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTOSAN POLYSULFATE SODIUM","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elmiron","Fibrase","Hemoclar","Sp 54"],"synonyms":["NSC-626201","PZ-68","PZ68","Pentosan polysulfate sodium","Pentosan polysulfate sodium salt","SP-54","SP54"],"crossReferences":{"DailyMed":["pentosan%20polysulfate%20sodium"],"DrugCentral":["2097"]},"count":4,"approvedIndications":["HP_0002619"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for varicose veins and has 3 investigational indications."}
{"id":"CHEMBL1201549","drugType":"Protein","blackBoxWarning":false,"name":"TERIPARATIDE ACETATE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Parathar"],"synonyms":["Ak159","HPTH 1-34","HPTH 1-34 (ACETATE SALT)","HPTH-1-34","Teriparatide acetate"],"count":4,"linkedTargets":{"rows":["ENSG00000160801"],"count":1},"linkedDiseases":{"rows":["EFO_1001494","EFO_0003854","EFO_0003882","Orphanet_567"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 4 investigational indications."}
{"id":"CHEMBL1201560","drugType":"Protein","blackBoxWarning":true,"name":"PEGINTERFERON ALFA-2A","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pegasys","Roferon-A"],"synonyms":["Peginterferon alfa-2a","RO 25-8310/000","RO-258310000"],"crossReferences":{"DailyMed":["peginterferon%20alfa-2a"],"DrugCentral":["5158"],"Wikipedia":["Peginterferon_alfa-2a"]},"count":25,"approvedIndications":["EFO_0004220","EFO_0004197"],"linkedTargets":{"rows":["ENSG00000159110","ENSG00000142166"],"count":2},"linkedDiseases":{"rows":["MONDO_0044903","EFO_0000756","MONDO_0007254","MONDO_0002087","EFO_0008496","EFO_0007304","EFO_0002430","EFO_0000565","MONDO_0002050","EFO_0000339","EFO_0000544","EFO_1000251","EFO_0000182","EFO_0004272","EFO_0003047","EFO_0000479","HP_0012115","EFO_0000616","MONDO_0008170","EFO_0000222","EFO_0004197","EFO_0002429","HP_0001873","EFO_0000311","EFO_0004239","EFO_1000026","EFO_0001422","EFO_0009260","EFO_0004220","EFO_0000095","EFO_0000764","MONDO_0002367","EFO_0001378","MONDO_0024880"],"count":34},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for hepatitis b virus infection and chronic hepatitis c virus infection and has 23 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201688","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"FOMIVIRSEN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fomivirsen"],"crossReferences":{"DrugCentral":["4751"],"Wikipedia":["Fomivirsen"]},"count":1,"approvedIndications":["EFO_1001888"],"description":"Oligonucleotide drug with a maximum clinical trial phase of IV and is indicated for eye infection."}
{"id":"CHEMBL1219","canonicalSmiles":"COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C","inchiKey":"YREYEVIYCVEVJK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RABEPRAZOLE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Aciphex","E-3810 (PPI)","E3810","LY-307640","LY307640","Rabeprazole"],"crossReferences":{"DailyMed":["rabeprazole%20sodium"],"Wikipedia":["Rabeprazole"],"drugbank":["DB01129"],"chEBI":["8768"]},"childChemblIds":["CHEMBL4303515","CHEMBL1200930"],"count":8,"approvedIndications":["EFO_0003948","HP_0004398"],"linkedTargets":{"rows":["ENSG00000105675"],"count":1},"linkedDiseases":{"rows":["HP_0002239","EFO_0004607","EFO_0007549","EFO_1001355","EFO_0000311","EFO_0008533","EFO_0003948","HP_0004398","MP_0001914","MONDO_0001056","EFO_0005741","EFO_0009454","EFO_0010282","EFO_0000253","EFO_0003763","EFO_1000961","EFO_1001095","EFO_0009878"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for peptic ulcer and gastroesophageal reflux disease and has 6 investigational indications."}
{"id":"CHEMBL1224745","canonicalSmiles":"CCCCCc1ccc(Oc2ccccc2)c(O)c1","inchiKey":"OJLYTHOKCYLPMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1224745","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07178"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229780","canonicalSmiles":"COC(=O)c1ccccc1S(=O)(=O)NC(=O)N(C)c1nc(C)nc(OC)n1","inchiKey":"VLCQZHSMCYCDJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIBENURON METHYL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tribenuron Methyl"],"crossReferences":{"PubChem":["144209747","26757182"],"drugbank":["DB03656"],"chEBI":["9678"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229989","canonicalSmiles":"CCCCCCCCCCCCSc1[nH]nnc1C(=O)O","inchiKey":"IEZPFPQAXAREGM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229989","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06979"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235806","canonicalSmiles":"NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(Br)cc2)cc1","inchiKey":"OYZKFVIVPRQRQQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235806","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03477"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236347","canonicalSmiles":"CC(=O)N[C@H]1[C@@H](OC[C@H](N)C(=O)O)O[C@H](CO)[C@H](O)[C@@H]1O","inchiKey":"REDMNGDGDYFZRE-WKWISIMFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236347","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02397"],"chEBI":["53608"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237007","canonicalSmiles":"O=C(O)c1cccnc1Nc1ccc(Cl)cc1","inchiKey":"YEXIXVLEDGNAKM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1237007","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["24809400"],"drugbank":["DB08784"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237072","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O","inchiKey":"WLOHNSSYAXHWNR-DWIOZXRMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIRITHROMYCIN","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dynabac"],"synonyms":["Dirithromycin","LY 237216","LY-237216"],"crossReferences":{"PubChem":["11532875","56422096"],"drugbank":["DB00954"],"chEBI":["474014"]},"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL12543","canonicalSmiles":"CN1CCCC1=O","inchiKey":"SECXISVLQFMRJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLPYRROLIDONE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-methylpyrrolidone","Methylpyrrolidone","N-Methyl Pyrrolidinone","N-methyl-pyrrolidone","NSC-4594"],"crossReferences":{"PubChem":["144209548","144210417"],"Wikipedia":["N-Methyl-2-pyrrolidone"],"drugbank":["DB12521"],"chEBI":["7307"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1279","canonicalSmiles":"CN[C@@H]1CCc2[nH]c3ccc(C(N)=O)cc3c2C1","inchiKey":"XPSQPHWEGNHMSK-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FROVATRIPTAN","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Migard","Mylatrip"],"synonyms":["Frova","Frovatriptan"],"crossReferences":{"DailyMed":["frovatriptan%20succinate"],"Wikipedia":["Frovatriptan"],"drugbank":["DB00998"]},"childChemblIds":["CHEMBL1200371","CHEMBL2138684"],"count":2,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546"],"count":2},"linkedDiseases":{"rows":["EFO_0003821","EFO_0003843"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for migraine disorder and has 1 investigational indication."}
{"id":"CHEMBL1329690","canonicalSmiles":"CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO.Cl","inchiKey":"QPAFAUYWVZMWPR-ZSOUGHPYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1329690","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1029","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["856023"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL139928","canonicalSmiles":"O=C(O)/C=C/c1ccc(B(O)O)cc1","inchiKey":"IEMLKNHGGSYOMP-ZZXKWVIFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-(4-Boronophenyl)Acrylic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-(4-Boronophenyl)Acrylic Acid","4-Phenylpropylester Boronic Acid"],"crossReferences":{"drugbank":["DB02503"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1405","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O","inchiKey":"DNXHEGUUPJUMQT-CBZIJGRNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESTRONE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Estrogenic substance","Estrone","Natural estrogenic substance-estrone","Oestrone","Theelin"],"synonyms":["Estrone","NSC-9699","Oestrone","Theelin","WAY 164397"],"crossReferences":{"PubChem":["11111162","11112119","144207116","144208573","144213953","170465020","26751561","26751562","50104169","56423156","855919","90340856"],"Wikipedia":["Estrone"],"drugbank":["DB00655"],"chEBI":["17263"]},"count":1,"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["EFO_0001073"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979 and has 1 investigational indication."}
{"id":"CHEMBL1422","canonicalSmiles":"N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F","inchiKey":"MFFMDFFZMYYVKS-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SITAGLIPTIN","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Januvia"],"synonyms":["LEZ-763","LEZ763","MK-0431","Sitagliptin"],"crossReferences":{"DailyMed":["sitagliptin%20phosphate"],"Wikipedia":["Sitagliptin"],"drugbank":["DB01261"],"chEBI":["40237"]},"childChemblIds":["CHEMBL1201174","CHEMBL539077","CHEMBL393336"],"count":18,"approvedIndications":["EFO_0000400"],"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["EFO_0003095","Orphanet_586","EFO_0000373","EFO_0003774","HP_0000083","EFO_1001459","EFO_0000712","EFO_0003884","EFO_0000182","EFO_0000676","EFO_0003047","EFO_0000400","EFO_0002546","MONDO_0013730","EFO_0000759","HP_0001952","EFO_0001074","EFO_0001645","EFO_0000180","HP_0011015","EFO_0001073","EFO_0000660","EFO_0000537","MONDO_0100096","EFO_0002614","EFO_1001121","EFO_0001359","HP_0003074","EFO_0008583","HP_0001943","EFO_0000612","EFO_0001360"],"count":32},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and is indicated for diabetes mellitus and has 17 investigational indications."}
{"id":"CHEMBL1445","canonicalSmiles":"C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"YLRFCQOZQXIBAB-RBZZARIASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUOXYMESTERONE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Android-f","Androxy","Fluoxymesterone","Halotestin","Ora-testryl"],"synonyms":["Fluoximesterone","Fluoxymesterone","Fluoxymesterone ciii","NSC-10704","NSC-12165"],"crossReferences":{"PubChem":["144206709","144208052","17388998","56422069"],"Wikipedia":["Fluoxymesterone"],"drugbank":["DB01185"],"chEBI":["5120"]},"count":1,"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956 and has 1 investigational indication."}
{"id":"CHEMBL1445834","canonicalSmiles":"NC12CC3CC(CC(C3)C1)C2.NC12CC3CC(CC(C3)C1)C2.O=C(O)/C=C\\C(=O)O","inchiKey":"QRVSGLPZAFQGCE-KSBRXOFISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1445834","maximumClinicalTrialPhase":0,"parentId":"CHEMBL660","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11113055"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1449018","canonicalSmiles":"CC(C)Nc1ccc(Nc2ccccc2)cc1","inchiKey":"OUBMGJOQLXMSNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1449018","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204720","144208622","144213519","17388854","56436647"],"drugbank":["DB14195"],"chEBI":["63569"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1464589","canonicalSmiles":"CNCCc1ccccn1.Cl","inchiKey":"PIIWYFURBFSHKM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1464589","maximumClinicalTrialPhase":0,"parentId":"CHEMBL24441","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["8139951"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL151649","canonicalSmiles":"S=C=NCCc1ccccc1","inchiKey":"IZJDOKYDEWTZSO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENETHYLISOTHIOCYANATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenethyl Isothiocyanate","Phenethylisothiocyanate","Phenylethyl Isothiocyanate"],"crossReferences":{"PubChem":["124400","144207298"],"Wikipedia":["Phenethyl_isothiocyanate"],"drugbank":["DB12695"],"chEBI":["351346"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1528134","canonicalSmiles":"CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12.Cl","inchiKey":"HNNIWKQLJSNAEQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZYDAMINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL12610","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Difflam","Difflam-p","Lozamine","Tantum"],"synonyms":["AF-864","Benzydamine hydrochloride"],"crossReferences":{"PubChem":["144203971","170465576","49665028"]},"count":1,"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_1001216","MONDO_0002258","EFO_1001904"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1539","canonicalSmiles":"COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC","inchiKey":"PJSFRIWCGOHTNF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFADOXINE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fanasil","Fanzil","Sulforthamidine","Sulphormethoxine"],"synonyms":["J21.373J","RO 4-4393","RO-4-4393","RO-44393","Sulfadoxine","WR-4073"],"crossReferences":{"PubChem":["11112518","144204074","170464751","56463175"],"Wikipedia":["Sulfadoxine"],"drugbank":["DB01299"],"chEBI":["9329"]},"count":7,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 7 investigational indications."}
{"id":"CHEMBL1570482","canonicalSmiles":"CCCCCCCC(=O)OCC(O)CO","inchiKey":"GHBFNMLVSPCDGN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MONOCTANOIN COMPONENT A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Monoctanoin component a"],"crossReferences":{"PubChem":["144205891","144211852","170465212","8139903"],"drugbank":["DB06801"],"chEBI":["85241"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1621597","canonicalSmiles":"CC(C)[N+]1(C)[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2","inchiKey":"OEXHQOGQTVQTAT-BHIXFJMTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPRATROPIUM","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ipratropium"],"crossReferences":{"DailyMed":["ipratropium%20bromide"],"drugbank":["DB00332"]},"childChemblIds":["CHEMBL1464005","CHEMBL2134724","CHEMBL3085123"],"count":2,"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","EFO_0002508","EFO_0008590","EFO_0000464","HP_0001742","EFO_0007214","HP_0006536","Orphanet_1764","EFO_0000270","EFO_0006505","EFO_1002018","EFO_0000341","HP_0025428","HP_0002307"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 2 investigational indications."}
{"id":"CHEMBL1626223","canonicalSmiles":"CN1CCCN=C1/C=C/c1cccs1","inchiKey":"YSAUAVHXTIETRK-AATRIKPKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRANTEL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Pyrantel"],"crossReferences":{"drugbank":["DB11156"],"chEBI":["8654"]},"childChemblIds":["CHEMBL2105309","CHEMBL1585303","CHEMBL1599768"],"count":1,"approvedIndications":["EFO_1001342"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for helminthiasis."}
{"id":"CHEMBL1628268","canonicalSmiles":"C#CCN(c1nc(-c2cc(C)c(OC)cc2Cl)c(C)s1)[C@@H](CC1CC1)c1ccc(C)c(F)c1.Cl","inchiKey":"BMXALUHUEGRRCH-JIDHJSLPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SR-125543A","maximumClinicalTrialPhase":0,"parentId":"CHEMBL291657","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SR-125543A"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1644","canonicalSmiles":"CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1","inchiKey":"BOEGTKLJZSQCCD-UEKVPHQBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFADROXIL","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Baxan","Cefadrops","Cefadroxil","Cefatabs","Duricef","Ultracef"],"synonyms":["BL-S578","Cefadroxil","Cefadroxil monohydrate","Cefadroxil/cefadroxil hemihydrate","MJF 11567-3","MJF-11567-3"],"crossReferences":{"DailyMed":["cefadroxil/cefadroxil%20hemihydrate"],"PubChem":["144204202","170464658","93576712"],"Wikipedia":["Cefadroxil"],"drugbank":["DB01140"],"chEBI":["3479"]},"count":3,"approvedIndications":["EFO_0000771","EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and is indicated for infection and bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL1651998","canonicalSmiles":"CC1(O)CCC(C(C)(C)O)CC1","inchiKey":"RBNWAMSGVWEHFP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERPIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-403856","Terpin"],"crossReferences":{"PubChem":["144205199","474118"],"Wikipedia":["Terpin_hydrate"]},"childChemblIds":["CHEMBL2105614"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1705373","canonicalSmiles":"COc1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc2c(c1OC)-c1ccc(SC)c(=O)cc1C(NC(C)=O)CC2","inchiKey":"LEQAKWQJCITZNK-MSQQGMGVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOCOLCHICOSIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-147755","Thiocolchicine 2-glucoside analog","Thiocolchicine glycoside","Thiocolchicoside"],"crossReferences":{"PubChem":["56463708"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1720","canonicalSmiles":"Cl.O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2","inchiKey":"OLDRWYVIKMSFFB-SSPJITILSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALONOSETRON HYDROCHLORIDE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1189679","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aloxi","Palonosetron hydrochloride"],"synonyms":["Palonosetron hydrochloride","RS-25259-197"],"crossReferences":{"DailyMed":["palonosetron%20hydrochloride"],"PubChem":["144205974","170465300"],"chEBI":["85157"]},"count":4,"approvedIndications":["EFO_0004888"],"linkedTargets":{"rows":["ENSG00000166736"],"count":1},"linkedDiseases":{"rows":["EFO_0006911","HP_0002017","EFO_0004888","EFO_0000311","HP_0002018"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for post operative nausea and vomiting and has 3 investigational indications."}
{"id":"CHEMBL17423","canonicalSmiles":"COc1ccc(C(=O)N2CCN(c3ccc4c(c3)CCC(=O)N4)CC2)cc1OC","inchiKey":"ZVNYJIZDIRKMBF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VESNARINONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Arkin"],"synonyms":["OPC-8212","Vesnarinone"],"crossReferences":{"Wikipedia":["Vesnarinone"],"drugbank":["DB12082"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1743034","drugType":"Antibody","blackBoxWarning":false,"name":"IXEKIZUMAB","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Taltz"],"synonyms":["Ixekizumab","LY-2439821","LY2439821"],"crossReferences":{"DailyMed":["ixekizumab"],"DrugCentral":["5083"]},"count":7,"approvedIndications":["EFO_0000676","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000112115"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","Orphanet_247353","EFO_1001494","Orphanet_2897","EFO_0001359","EFO_0003898","EFO_0000676","EFO_0003778","HP_0000999","EFO_0000540","EFO_0007187"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for immune system disease and psoriasis and has 5 investigational indications."}
{"id":"CHEMBL1743078","drugType":"Antibody","blackBoxWarning":false,"name":"TEPLIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HOKT3-GAMMA-1 (ALA-ALA)","HUMANIZED OKT3","Humanzied OKT3","MGA-031","MGA031","Teplizumab","hOKT3 gamma 1 (Ala-Ala)"],"count":3,"linkedTargets":{"rows":["ENSG00000198851"],"count":1},"linkedDiseases":{"rows":["EFO_0001359","EFO_0000676","EFO_0002546"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1939499","canonicalSmiles":"N#Cc1cc(Cl)cc(Oc2c(Cl)ccc3c2cnn3Cc2n[nH]c3ncccc23)c1","inchiKey":"FZBAOOQVQXATRL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-6186","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-6186","MK6186","Mk-6186","Mk6186"],"crossReferences":{"drugbank":["DB12999"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1989587","canonicalSmiles":"CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CC(C=O)=C4C=C(OCCCl)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C","inchiKey":"QNXUUBBKHBYRFW-QWAPGEGQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORMOCORTAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Deflamene","Fluderma"],"synonyms":["Formocortal"],"crossReferences":{"PubChem":["301208"],"drugbank":["DB13664"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2000716","canonicalSmiles":"NC(=O)CN1C=CCC(C(N)=O)=C1","inchiKey":"WEJRSYKFMCUCRQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARICOTAMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Caricotamide"],"crossReferences":{"PubChem":["534303"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2011961","canonicalSmiles":"O=C1O[C@H]([C@@H](O)CO)C(O)=C1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"MLSJBGYKDYSOAE-DCWMUDTNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2011961","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11335"],"chEBI":["81685"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL201880","canonicalSmiles":"CCCc1c(OCCCOc2ccc3c(ccn3CC(=O)O)c2)ccc2cc(C(=O)c3ccccc3)ccc12","inchiKey":"ZXWVCCFKIRBLDP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL201880","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04689"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL203665","canonicalSmiles":"CC(C)C[C@H](NC(=O)c1cc2ccccc2o1)C(=O)N[C@H]1CC[C@@H](C)N(S(=O)(=O)c2ccccn2)CC1=O","inchiKey":"BWYBBMQLUKXECQ-GIVPXCGWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RELACATIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Relacatib","SB-462795"],"crossReferences":{"drugbank":["DB06367"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2074689","canonicalSmiles":"Cl.Cl.Cl.O[C@@H](COc1cccc2ncccc12)CN1CCN([C@@H]2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1","inchiKey":"ZPFVQKPWGDRLHL-WITOOOCMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOSUQUIDAR TRIHYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL444172","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zosuquidar trihydrochloride"],"crossReferences":{"PubChem":["170465595"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL208239","canonicalSmiles":"CS(=O)(=O)c1ccc(CN2CCN(c3cn[nH]c3-c3cc(Cl)c(O)cc3O)CC2)cc1","inchiKey":"BDFJIEMVNDLSTB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL208239","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06957"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2096646","canonicalSmiles":"Nc1ccc(C(=O)[O-])c(O)c1.O.O.[Na+]","inchiKey":"GMUQJDAYXZXBOT-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOSALICYLATE SODIUM","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1169","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["P.a.s. sodium","Parasal sodium","Sodium aminosalicylate","Sodium p.a.s.","Teebacin"],"synonyms":["Aminosalicylate sodium","Aminosalyle sodium","Sodium Aminosalicylate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1950."}
{"id":"CHEMBL2096648","canonicalSmiles":"N[13C](N)=O","inchiKey":"XSQUKJJJFZCRTK-OUBTZVSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UREA C 13","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL985","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Breathtek ubt for h-pylori","Helicosol","Meretek ubt kit (w/ pranactin)","Pylori-chek breath test"],"synonyms":["Urea (13C)","Urea c 13","Urea c-13"],"crossReferences":{"drugbank":["DB09510"],"chEBI":["32285"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1996."}
{"id":"CHEMBL209740","canonicalSmiles":"CCOc1nc(C(=O)NCc2cc(OC)ccc2OC)ccc1C#N","inchiKey":"VEGKZYFYGCWXMN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL209740","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07276"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103743","canonicalSmiles":"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"SYIKUFDOYJFGBQ-YLAFAASESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOFACITINIB CITRATE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL221959","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xeljanz","Xeljanz xr"],"synonyms":["CP-690,550-10","CP-690550-10","Tasocitinib citrate","Tofacitinib citrate","Tofacitinib monocitrate"],"crossReferences":{"DailyMed":["tofacitinib%20citrate"],"chEBI":["71197"]},"count":2,"approvedIndications":["EFO_0000685"],"linkedTargets":{"rows":["ENSG00000096968","ENSG00000162434","ENSG00000105639","ENSG00000105397"],"count":4},"linkedDiseases":{"rows":["EFO_0000685","EFO_0002690","MONDO_0019558"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for rheumatoid arthritis and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2103800","drugType":"Small molecule","blackBoxWarning":false,"name":"COLESTILAN CHLORIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bindren","Cholebine (japan)"],"synonyms":["Colestilan","Colestilan chloride","Colestimide","MCI-196"],"crossReferences":{"DrugCentral":["4851"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2103813","canonicalSmiles":"CCCCC(CC)COC(=O)c1ccc(Nc2nc(Nc3ccc(C(=O)NC(C)(C)C)cc3)nc(Nc3ccc(C(=O)OCC(CC)CCCC)cc3)n2)cc1","inchiKey":"OSCJHTSDLYVCQC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISCOTRIZINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Uvasorb heb"],"synonyms":["DIETHYLHEXYL BUTAMIDO TRIAZONE (INCI)","Iscotrizinol"],"crossReferences":{"drugbank":["DB15468"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103868","canonicalSmiles":"COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC.O=C(O)C[C@H](O)C(=O)O","inchiKey":"HFCFMRYTXDINDK-WNQIDUERSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CABOZANTINIB S-MALATE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2105717","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cabometyx","Cometriq"],"synonyms":["BMS-907351","Cabozantinib s-malate","XL-184","XL184"],"crossReferences":{"DailyMed":["cabozantinib%20s-malate"],"chEBI":["72319"]},"count":16,"approvedIndications":["EFO_0002892","MONDO_0002108","EFO_0000641"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000105976"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000616","EFO_1000592","MONDO_0002108","EFO_0000349","EFO_1001465","EFO_1001512","EFO_0000272","EFO_0003060","EFO_0000311","EFO_0000640","EFO_1000489","EFO_0003968","EFO_0002892","EFO_0000182","EFO_0008524","EFO_0000501","EFO_0000326","EFO_0000641","EFO_0000563","EFO_0000239","EFO_0000519"],"count":22},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 3 approved and 13 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2104089","canonicalSmiles":"CC(C)(N)CO.Cn1c(=O)c2[nH]cnc2n(C)c1=O","inchiKey":"SEIRRUDMPNNSCY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMBUPHYLLINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL190","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Butaphyllamine"],"synonyms":["Ambuphylline","Bufylline"],"crossReferences":{"DrugCentral":["4426"],"drugbank":["DB13812"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104356","canonicalSmiles":"CC1=CC(=O)N2CC(=O)N(C)c3ccc(Cl)cc3C2(c2ccccc2)O1","inchiKey":"PWAJCNITSBZRBL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KETAZOLAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anxon"],"synonyms":["Ketazolam","U-28,774"],"crossReferences":{"drugbank":["DB01587"]},"count":1,"approvedIndications":["EFO_0005230"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for anxiety."}
{"id":"CHEMBL2104751","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C(OC(C)=O)=CC[C@H]4[C@@H](C2)N(C)CC[C@]314","inchiKey":"RRJQTGHQFYTZOW-ILWKUFEGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THEBACON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Thebacon"],"crossReferences":{"drugbank":["DB13458"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105032","canonicalSmiles":"COC(=O)C[C@@H]1C[C@@H](COc2ccc(-c3ccc(C(=N)NC(=O)OC)cc3)cc2)NC1=O","inchiKey":"PGCFXITVMNNKON-ROUUACIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEFRADAFIBAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lefradafiban"],"crossReferences":{"drugbank":["DB04863"],"chEBI":["60634"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105187","canonicalSmiles":"CN1[C@@H]2CCC(C)(C)[C@H]1C[C@H](OC(=O)C(O)(c1cccs1)c1cccs1)C2","inchiKey":"AMHPTVWBZSYFSS-BZUAXINKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAZATICOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mazaticol","Mazaticol hydrochloride","PG-501"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105206","canonicalSmiles":"c1ccc(-c2cc(CCC3CCNCC3)c3ccccc3n2)cc1","inchiKey":"AMEWZCMTSIONOX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPEQUALINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pipequaline"],"crossReferences":{"drugbank":["DB13991"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105616","canonicalSmiles":"CC(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O","inchiKey":"GUCKKCMJTSNWCU-BQBZGAKWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPAGLUMIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Spaglumic acid"],"crossReferences":{"PubChem":["144204096"],"drugbank":["DB08835"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105649","canonicalSmiles":"CN1CCN(c2cccc3[nH]c(=O)oc23)CC1.Cl","inchiKey":"NQRIKTDKFHAOKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARDOPRUNOX HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2103832","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DU 126891 HYDROCHLORIDE","Pardoprunox hydrochloride","SLV 308 HYDROCHLORIDE"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105945","canonicalSmiles":"CC(=O)N[C@H]([C@@H](O)CC(=O)C(=O)O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"KBGAYAKRZNYFFG-BOHATCBPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACENEURAMIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aceneuramic acid","UX001"],"crossReferences":{"PubChem":["144205940"],"drugbank":["DB11797"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2106041","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)[C@H](O)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O","inchiKey":"OIDGWOIMPADMGM-GXSWRUKYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"AVIPTADIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aviptadil","Vip human vip"],"crossReferences":{"drugbank":["DB06260"]},"count":4,"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["EFO_0004610","EFO_0000694","HP_0002094","MONDO_0100096","EFO_1000637"],"count":5},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2106851","canonicalSmiles":"CN1CC[C@]23c4c5ccc(OC(=O)c6cccnc6)c4O[C@H]2[C@@H](OC(=O)c2cccnc2)C=C[C@H]3[C@H]1C5","inchiKey":"HNDXBGYRMHRUFN-CIVUWBIHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOMORPHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nicomorphine"],"crossReferences":{"drugbank":["DB13454"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107312","canonicalSmiles":"CC(C)C(=O)O[C@@H](OC(=O)NC[C@H](CC(=O)O)c1ccc(Cl)cc1)C(C)C","inchiKey":"JXTAALBWJQJLGN-KSSFIOAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARBACLOFEN PLACARBIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arbaclofen placarbil","XP-19986","XP19986"],"crossReferences":{"drugbank":["DB08892"]},"count":5,"linkedTargets":{"rows":["ENSG00000136928","ENSG00000204681"],"count":2},"linkedDiseases":{"rows":["EFO_0003885","EFO_0003948","HP_0001257","HP_0003418","EFO_0003829"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2107419","canonicalSmiles":"C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C(C=O)=C[C@]4(C)[C@H]3[C@H](O)C[C@@]21C","inchiKey":"AMVODTGMYSRMNP-GNIMZFFESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORMEBOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Formebolone"],"crossReferences":{"drugbank":["DB01569"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107855","drugType":"Protein","blackBoxWarning":false,"name":"DENENICOKIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-982470","Denenicokin","IL-21","IL-21 RECOMBINANT","RECOMBINANT HUMAN INTERLEUKIN 21","RIL-21","RIL-21; RECOMBINANT HUMAN INTERLEUKIN 21"],"count":4,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2107856","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"IMETELSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GRN-163L","GRN163L","Imetelstat"],"count":9,"linkedTargets":{"rows":["ENSG00000164362"],"count":1},"linkedDiseases":{"rows":["EFO_0002430","EFO_0000198","MONDO_0044903","MONDO_0007254","EFO_0000574","EFO_0001378","EFO_0002429","EFO_0000621","EFO_0003060","EFO_0000479"],"count":10},"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2108239","drugType":"Protein","blackBoxWarning":false,"name":"CILMOSTIM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Macstim"],"synonyms":["Cilmostim","Csf-1","M-csf","Rhm-csf"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108358","drugType":"Protein","blackBoxWarning":false,"name":"SERELAXIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RLX-030","RLX030","Serelaxin"],"count":5,"linkedTargets":{"rows":["ENSG00000133105","ENSG00000171509"],"count":2},"linkedDiseases":{"rows":["EFO_0003144","EFO_0001645","EFO_0003884","EFO_0001421","EFO_0000319","EFO_0000668"],"count":6},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108618","drugType":"Cell","blackBoxWarning":false,"name":"LITGENPROSTUCEL-L","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Gvax prostate"],"synonyms":["CG8711","Litgenprostucel-l"],"count":1,"description":"Cell drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108717","drugType":"Cell","blackBoxWarning":false,"name":"ALGENPANTUCEL-L","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hyperacute-pancreas immunotherapy"],"synonyms":["Algenpantucel-l","HAPA"],"count":1,"description":"Cell drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108784","drugType":"Antibody","blackBoxWarning":false,"name":"ZIRALIMUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABX-RB2","Ziralimumab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108893","drugType":"Enzyme","blackBoxWarning":false,"name":"ALFIMEPRASE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alfimeprase"],"count":2,"description":"Enzyme drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109250","drugType":"Antibody","blackBoxWarning":false,"name":"TGN-1412","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CD28-SUPERMAB","TAB-08","TGN-1412","Tgn-1412"],"count":4,"linkedTargets":{"rows":["ENSG00000178562"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000685","EFO_1001494","EFO_0002690"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109348","drugType":"Antibody","blackBoxWarning":false,"name":"LFB-R603","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LFB-R603","Lfb-r603"],"count":1,"linkedTargets":{"rows":["ENSG00000156738"],"count":1},"linkedDiseases":{"rows":["EFO_0000095"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109384","drugType":"Antibody","blackBoxWarning":false,"name":"DEMCIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Demcizumab","OMP-21M18"],"count":4,"linkedTargets":{"rows":["ENSG00000128917"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","MONDO_0015686","EFO_0003060","EFO_1001951"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2111144","canonicalSmiles":"Cc1nn(C)c2c1C(c1ccccc1F)=NCC(=O)N2C","inchiKey":"GDSCFOSHSOWNDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOLAZEPAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zolazepam"],"crossReferences":{"drugbank":["DB11555"]},"childChemblIds":["CHEMBL2107559"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2218919","canonicalSmiles":"C=C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C","inchiKey":"BICRTLVBTLFLRD-JDCIFRKPSA-N","drugType":"Protein","blackBoxWarning":false,"name":"VOCLOSPORIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ISA-247","ISA247","ISATX-247","ISATX247","LX-211","LX211","Voclosporin"],"count":9,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2219774","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"GATAPARSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gataparsen","LY-2181308","LY2181308"],"childChemblIds":["CHEMBL2219775"],"count":4,"description":"Oligonucleotide drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL226471","canonicalSmiles":"O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21","inchiKey":"XJJYJNMNYDNXNO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL226471","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["103904965"],"drugbank":["DB07728"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2311030","canonicalSmiles":"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CCC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O","inchiKey":"PBKVEOSEPXMKDN-LZHUFOCISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERGOLOID MESYLATES","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2364968","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alkergot","Circanol","Deapril","Deapril-st","Ergoloid mesylates","Gerimal","Hydergine","Hydergine lc","Hydrogenated ergot alkaloids"],"synonyms":["Co-dergocrine mesilate","Co-dergocrine mesylate","Dihydroergotoxine mesilate","Dihydroergotoxine mesylate","Dihydroergotoxine methanesulfonate","Dihydrogenated ergot alkaloids","Ergoloid mesylates","Hydrogenated ergot alkaloids"],"crossReferences":{"DailyMed":["ergoloid%20mesylates"],"DrugCentral":["5035"]},"count":2,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000178394","ENSG00000135312","ENSG00000274286","ENSG00000184845","ENSG00000149295","ENSG00000069696","ENSG00000151577","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000169676","ENSG00000150594"],"count":13},"linkedDiseases":{"rows":["EFO_0004718","EFO_0000319"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and is indicated for cardiovascular disease and has 1 investigational indication."}
{"id":"CHEMBL2381848","canonicalSmiles":"CCC[C@H](Oc1cc(C)c(-n2cc(C(F)(F)F)cn2)c(C)c1)c1ccc(C(=O)NCCC(=O)O)cc1","inchiKey":"IBDYYOQKQCCSDP-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2381848","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15065"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2386081","canonicalSmiles":"O=C(O)Cn1c2c(c3cc(F)ccc31)CN(C(=O)c1cccc3ccccc13)CC2","inchiKey":"IHAXLPDVOWLUOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SETIPIPRANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACT-129968","KYTH-105","Setipiprant"],"crossReferences":{"drugbank":["DB12562"]},"count":3,"linkedTargets":{"rows":["ENSG00000183134"],"count":1},"linkedDiseases":{"rows":["Orphanet_79364","EFO_0000270","EFO_0003956"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL249856","canonicalSmiles":"CSc1ccc(C(=O)c2[nH]c(=O)[nH]c2C)cc1","inchiKey":"ZJKNESGOIKRXQY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENOXIMONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Perfan"],"synonyms":["Enoximone","MDL 17,043","MDL-17043"],"crossReferences":{"PubChem":["11111134","144203688","170466419","50106183","56320891","56320892","85231030","90340640"],"Wikipedia":["Enoximone"],"drugbank":["DB04880"]},"count":2,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 1 investigational indication."}
{"id":"CHEMBL251074","canonicalSmiles":"CC(=O)C[C@@H](c1ccccc1)c1c(O)c2ccccc2oc1=O","inchiKey":"PJVWKTKQMONHTI-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"S-Warfarin","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["S-Warfarin"],"crossReferences":{"PubChem":["29217692"],"drugbank":["DB14055"],"chEBI":["87738"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL258558","canonicalSmiles":"CC(C)(c1ccc(OCC2CO2)cc1)c1ccc(OCC2CO2)cc1","inchiKey":"LCFVJGUPQDGYKZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL258558","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144209339","144213632","17389141","26752169","26752170","26752171"],"drugbank":["DB14083"],"chEBI":["34578"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL25856","canonicalSmiles":"Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2","inchiKey":"BGOQGUHWXBGXJW-RHSMWYFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDREXIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DAR-0100","Dar-0100a","Dihydrexidine","Rel-Dihydrexidine"],"crossReferences":{"PubChem":["11111082","124886952"],"Wikipedia":["Dihydrexidine"]},"childChemblIds":["CHEMBL1461491","CHEMBL1256832"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL266349","canonicalSmiles":"N=C(N)c1ccc(CNC(=O)[C@@H]2CCN2C(=O)[C@H](NCC(=O)O)C2CCCCC2)cc1","inchiKey":"DKWNMCUOEDMMIN-PKOBYXMFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MELAGATRAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Melagatran"],"crossReferences":{"drugbank":["DB13616"],"chEBI":["43966"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL277238","canonicalSmiles":"O=C(N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](S)Cc1ccccc1","inchiKey":"GIVBBFGMRNXKPE-HJOGWXRNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL277238","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03949"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL278703","canonicalSmiles":"Oc1ccc([C@@H]2Oc3ccc(O)cc3[C@@H]3CCC[C@@H]32)cc1","inchiKey":"XIESSJVMWNJCGZ-VKJFTORMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERTEBEREL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Erteberel","LY-500307","LY500307"],"crossReferences":{"drugbank":["DB07933"]},"count":2,"linkedTargets":{"rows":["ENSG00000140009"],"count":1},"linkedDiseases":{"rows":["EFO_0000284","EFO_0000692"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL289228","canonicalSmiles":"Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C","inchiKey":"PLHJCIYEEKOWNM-HHHXNRCGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIPIFARNIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-11577","R-115777","R115777","Tipifarnib"],"crossReferences":{"Wikipedia":["Tipifarnib"],"drugbank":["DB04960"]},"count":43,"linkedTargets":{"rows":["ENSG00000168522","ENSG00000257365"],"count":2},"linkedDiseases":{"rows":["EFO_0003869","EFO_0000756","EFO_1001933","EFO_1001465","MONDO_0007254","EFO_1001469","EFO_0003026","EFO_0000305","EFO_1000984","MONDO_0020654","MONDO_0001187","EFO_0000632","EFO_0000565","EFO_0002430","EFO_1001951","MONDO_0021310","EFO_1000044","EFO_0000339","MONDO_0021633","MONDO_0003165","MONDO_0008903","EFO_1001932","EFO_0008528","MONDO_0003869","EFO_1000158","EFO_0000479","EFO_0000198","EFO_0002618","EFO_0000616","EFO_1001779","MONDO_0002108","EFO_0002939","EFO_0000222","EFO_0000223","EFO_1000309","MONDO_0019469","EFO_0002429","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_0003028","EFO_0006861","EFO_0000095","EFO_0005235","EFO_0002428","EFO_0001378","EFO_0000218","EFO_0000519","EFO_0003027"],"count":49},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 43 investigational indications."}
{"id":"CHEMBL29292","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O","inchiKey":"VGGGPCQERPFHOB-RDBSUJKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UBENIMEX","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-265489","Ubenimex"],"crossReferences":{"PubChem":["11114244","26752255","90341182"],"Wikipedia":["Ubenimex"],"drugbank":["DB03424"]},"childChemblIds":["CHEMBL538595"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL29411","canonicalSmiles":"Cc1ccc(C(C)C)c(O)c1","inchiKey":"MGSRCZKZVOBKFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THYMOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eftab","Gppe mthwsh tab","Listerine","Sotol","Tellodont","Tellora","Valda"],"synonyms":["FEMA NO. 3066","NSC-11215","NSC-47821","NSC-49142","Thymol"],"crossReferences":{"PubChem":["144205166","144210676","170465504","29215297","47193695"],"Wikipedia":["Thymol"],"drugbank":["DB02513"],"chEBI":["27607"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL3184600","canonicalSmiles":"CN[C@H]1[C@@H](O)[C@@H](NC)[C@H](O)[C@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]12.Cl.Cl","inchiKey":"FOGDPGQSHLLYIK-XYQGXRRISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3184600","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1167","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204143","170465149"],"chEBI":["9216"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3215298","canonicalSmiles":"CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\\C=C\\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O","inchiKey":"IBSREHMXUMOFBB-JFUDTMANSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"ABAMECTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Endecto","Enzec","Enzek","Parafoil","Vertimil","Zectin"],"synonyms":["Abamectin","MK-0936","MK-936"],"crossReferences":{"PubChem":["144211158"]},"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL32479","canonicalSmiles":"Cc1nnc2n1-c1sc(Br)cc1C(c1ccccc1Cl)=NC2","inchiKey":"UMSGKTJDUHERQW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROTIZOLAM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lendorm"],"synonyms":["Brotizolam","WE 941","WE-941","WE-941-BS"],"crossReferences":{"PubChem":["144207150"],"Wikipedia":["Brotizolam"],"drugbank":["DB09017"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3301604","canonicalSmiles":"O=C(O)COC[C@H]1CC[C@H](COC(=O)N(c2ccccc2)c2ccc(Cl)cc2)CC1","inchiKey":"NPDKXVKJRHPDQT-IYARVYRRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RALINEPAG","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APD-811","APD811","Ralinepag"],"crossReferences":{"drugbank":["DB12462"]},"childChemblIds":["CHEMBL3961431"],"count":1,"linkedTargets":{"rows":["ENSG00000160013"],"count":1},"linkedDiseases":{"rows":["EFO_0001361"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3301616","canonicalSmiles":"CS(=O)(=O)O.Cc1nc(NNC(=O)[C@H](CC2CCCC2)CN(O)C=O)c(F)c(N2CCN3CCOC[C@@H]3C2)n1","inchiKey":"UNGNACZMQRGYNV-URBRKQAFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LANOPEPDEN MESYLATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL3301608","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-1322322 MESYLATE SALT","GSK-1322322J","GSK1322322 MESYLATE SALT","GSK1322322J","Lanopepden mesilate","Lanopepden mesylate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3301681","canonicalSmiles":"CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O","inchiKey":"ULLNJSBQMBKOJH-VIVFLBMVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIBENOSIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["21401-BA","Tribenoside"],"crossReferences":{"drugbank":["DB13227"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL336296","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"PGAVKCOVUIYSFO-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URIDINE TRIPHOSPHATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INS-316","INS316","UTP","Uridine 5'-triphosphate","Uridine triphosphate","Uridine-5'-triphosphate"],"crossReferences":{"PubChem":["26756678"],"drugbank":["DB04005"],"chEBI":["15713"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL341812","canonicalSmiles":"CC(C)Cc1ccc(CC(=O)O)cc1","inchiKey":"CYWFCPPBTWOZSF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBUFENAC","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Hepatotoxicity"],"year":1968},"tradeNames":["Dytransin"],"synonyms":["Ibufenac","RD 11654"],"crossReferences":{"PubChem":["170465922","29216132"],"chEBI":["76158"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom  in 1968 due to Hepatotoxicity."}
{"id":"CHEMBL343633","canonicalSmiles":"CC(C)NC[C@H](O)COc1ccc(CC(N)=O)cc1","inchiKey":"METKIMKYRPQLGS-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESATENOLOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Esatenolol","S-Atenolol","S-atenolol"],"crossReferences":{"PubChem":["11110679","11110681","11112794","11112795","11113477","11113481","124882641","26751699","26753528","50104390","50104391","50105883","50105884","56463525","85231336","90341383"],"drugbank":["DB13443"],"chEBI":["31556"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL34964","canonicalSmiles":"OB(O)c1cc2ccccc2s1","inchiKey":"YNCYPMUJDDXIRH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Benzo[B]Thiophen-2-Boronic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzo[B]Thiophen-2-Boronic Acid","Benzo[B]Thiophen-2-Ylboronic Acid","Benzo[B]Thiophene-2-Boronic Acid","Benzo[B]Thiophene2-Boronic Acid","Bnezo[B]Thiophen-2-Boronic Acid"],"crossReferences":{"PubChem":["26753145"],"drugbank":["DB04360"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3527000","canonicalSmiles":"O=c1[nH]nc2c3cc(CN4CCC(O)CC4)ccc3oc3cccc1c32","inchiKey":"HAVFFEMDLROBGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"E-7016","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E 7016","E-7016","GPI-21016"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545139","drugType":"Small molecule","blackBoxWarning":false,"name":"PS-516895","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ps-516895"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545220","drugType":"Small molecule","blackBoxWarning":false,"name":"LY2590443","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ly2590443"],"count":1,"linkedTargets":{"rows":["ENSG00000148680"],"count":1},"linkedDiseases":{"rows":["EFO_0003821"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545261","drugType":"Antibody","blackBoxWarning":false,"name":"BRONTICTUZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Brontictuzumab","OMP-52M51"],"count":2,"linkedTargets":{"rows":["ENSG00000148400"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001480","EFO_0000311"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545272","drugType":"Small molecule","blackBoxWarning":false,"name":"LAS190792","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Las190792"],"count":2,"linkedTargets":{"rows":["ENSG00000169252","ENSG00000133019"],"count":2},"linkedDiseases":{"rows":["EFO_0000270","EFO_0000341"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545425","drugType":"Small molecule","blackBoxWarning":false,"name":"BAY-1161909","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-BAY-1161909","BAY 1161909","Bay-1161909","Empesertib","MPS1-IN-5"],"count":1,"linkedTargets":{"rows":["ENSG00000112742"],"count":1},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545428","drugType":"Small molecule","blackBoxWarning":false,"name":"CHIAURANIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CS-2164","CS2164","Chiauranib","Cs-2164"],"count":5,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000178999","ENSG00000102755","ENSG00000037280"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0008170","EFO_0000182","EFO_0000702","EFO_0005952"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3661115","canonicalSmiles":"CCc1cc(C(N)=O)ccc1-n1nc(C(C)C)c2c(-n3cnc(-c4cnn(C)c4)c3)ccnc21","inchiKey":"NVVPMZUGELHVMH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAS-116","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pimitespib","TAS-116","Tas 116","Tas-116"],"crossReferences":{"drugbank":["DB14876"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3693786","canonicalSmiles":"O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2Cl)nc1)NO","inchiKey":"VLIUIBXPEDFJRF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CITARINOSTAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACY-241","Citarinostat","HDAC-IN-2"],"crossReferences":{"drugbank":["DB15449"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3707290","canonicalSmiles":"C=C(CCCCCCCCCCCCCCCc1nnn[nH]1)NS(=O)(=O)CCCC(=O)NCCOCCOCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)N[C@@H](CCCCNC(=O)CSC[C@H](N)C(=O)O)C(N)=O)C(=O)O)C(=O)O","inchiKey":"NAKSIOUBFDBTSW-ITMZJIMRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOMAPACITAN","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sogroya"],"synonyms":["NN-8640","NN8640","NNC-0195-0092","NNC0195-0092","Somapacitan","Somapacitan-beco"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020."}
{"id":"CHEMBL3707382","drugType":"Enzyme","blackBoxWarning":false,"name":"VESTRONIDASE ALFA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["UX-003","UX003","Vestronidase alfa"],"crossReferences":{"DailyMed":["vestronidase%20alfa-vjbk"]},"count":2,"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL38943","canonicalSmiles":"Cc1cc(SCc2sc(-c3ccc(C(F)(F)F)cc3)nc2C)ccc1OCC(=O)O","inchiKey":"YDBLKRPLXZNVNB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW501516","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-516","GW-1516","GW501516","Gw501516"],"crossReferences":{"PubChem":["137275846","99460836"],"Wikipedia":["GW501516"],"drugbank":["DB05416"],"chEBI":["73726"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL389471","canonicalSmiles":"CO[C@H]1[C@H](OC(=O)c2ccc(C)[nH]2)[C@H](O)[C@@H](Oc2ccc3c(O)c(NC(=O)c4c[nH]c(C(=O)Nc5c(O)c6ccc(O[C@H]7OC(C)(C)[C@@H](OC)[C@H](OC(=O)c8ccc(C)[nH]8)[C@@H]7O)c(C)c6oc5=O)c4C)c(=O)oc3c2C)OC1(C)C","inchiKey":"WTIJXIZOODAMJT-IYKSDEDASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COUMERMYCIN A1","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Coumermycin A1"],"crossReferences":{"drugbank":["DB13912"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL394429","canonicalSmiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"GYOZYWVXFNDGLU-XLPZGREQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THYMIDINE MONOPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-Deoxythymidine Monophosphate","Thymidine Monophosphate","Thymidine-5'-Phosphate"],"crossReferences":{"Wikipedia":["Thymidine_monophosphate"],"drugbank":["DB01643"],"chEBI":["17013"]},"childChemblIds":["CHEMBL1627078"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL396290","canonicalSmiles":"COc1ccc(/C=C/C(=O)OCCCCO[N+](=O)[O-])cc1OC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"RISQVQFWBQSZQE-OBOLPPCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NCX 1000","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ncx 1000"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3989517","canonicalSmiles":"COC(=O)[C@H]1[C@@H](c2ccc([123I])cc2)C[C@@H]2CC[C@H]1N2CCCF","inchiKey":"HXWLAJVUJSVENX-HFIFKADTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOFLUPANE I 123","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1945778","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Datscan"],"synonyms":["Iodine ioflupane (123i)","Ioflupane (123i)","Ioflupane i 123","Ioflupane i-123","V-09AB03","V09AB03"],"crossReferences":{"DailyMed":["ioflupane%20i-123"],"drugbank":["DB08824"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2011 and has 1 investigational indication."}
{"id":"CHEMBL3989595","canonicalSmiles":"CCN(CC)CCn1c2c(c3ccc(OC)cc31)CCN1C[C@H]3C[C@@H](OC(=O)c4cc(OC)c(OC)c(OC)c4)[C@H](OC)[C@@H](C(=O)OC)[C@H]3C[C@H]21","inchiKey":"WFTSRDISOMSAQC-ZNFOTRSXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIETASERPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bietaserpine","DL 152","S-1210"],"crossReferences":{"drugbank":["DB13575"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989705","canonicalSmiles":"CCC(=O)[O-].O.[Na+]","inchiKey":"HOAUAOBUGFYWMK-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM PROPIONATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL500826","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sodium propionate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3989801","canonicalSmiles":"CC(=O)O.CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](COP(=O)(O)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)CC)C(C)C","inchiKey":"AAYJNPGTWYJOET-VURLEEIPSA-N","drugType":"Protein","blackBoxWarning":false,"name":"FORIGERIMOD ACETATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL3989409","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lupuzor"],"synonyms":["CEP-33457","Forigerimod acetate","IPP 201101","P-140","P140"],"count":1,"linkedTargets":{"rows":["ENSG00000109971"],"count":1},"linkedDiseases":{"rows":["EFO_0002690"],"count":1},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4063475","canonicalSmiles":"C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O.O","inchiKey":"XDJUBZFLFDODNF-PPHPATTJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4063475","maximumClinicalTrialPhase":0,"parentId":"CHEMBL459","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL413376","canonicalSmiles":"Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)[O-])c3cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)[O-])c5cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c45)ccc3C)c2)c1.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]","inchiKey":"VAPNKLKDKUDFHK-UHFFFAOYSA-H","drugType":"Small molecule","blackBoxWarning":false,"name":"SURAMIN HEXASODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL265502","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CI-1003","FOURNEAU 309","Naphuride","Suramin hexasodium","Suramin sodium"],"crossReferences":{"PubChem":["11112082","124881892","26747683","26753666","85231329"]},"count":14,"linkedTargets":{"rows":["ENSG00000113578"],"count":1},"linkedDiseases":{"rows":["EFO_0003756","DOID_10113","EFO_0005044","HP_0001919","EFO_0000681","MONDO_0007254","MONDO_0008315","EFO_0003060","MONDO_0001187","EFO_1001951","EFO_0007294","EFO_0000673","EFO_0006544","EFO_0001378","EFO_1000796","EFO_1000158"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL4173974","canonicalSmiles":"C[C@@H]1CN(CC(=O)N2CC(C)(C)c3nc(CO)c(Cc4ccc(F)cc4)cc32)[C@@H](CN2CCOC[C@H]2C)CN1","inchiKey":"YCXOHEXZVKOGEV-DNRQZRRGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASTX-660","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASTX-660","ASTX660","Astx 660","Astx-660","Astx660"],"childChemblIds":["CHEMBL4176251","CHEMBL4165643"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4206492","canonicalSmiles":"O=c1[nH]c(Cc2ccccn2)nc2c1cnn2C1CCOCC1","inchiKey":"BZTIJCSHNVZMES-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSORESNONTRINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 409306","BI-409306","Bi 409306","Osoresnontrine","SUB 166499"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297063","canonicalSmiles":"CC(O)C(=O)O.CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1.O","inchiKey":"QDPVYZNVVQQULH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOVITINIB LACTATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL522892","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHIR-258","Dovitinib lactate","Dovitinib lactate hydrate"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297087","canonicalSmiles":"CCN(CC)CCCOC(=O)C1(c2ccccc2)CC2CCC1C2","inchiKey":"BDNMABJZSXTKAQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BORNAPRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bornaprine"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297283","canonicalSmiles":"CCCCN1C[C@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@H](OC(=O)CCC)[C@H]1COC(=O)CCC","inchiKey":"MKGDNVHZSCXBKR-KYVQNOJUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCOVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glycovir","NSC-670880"],"crossReferences":{"drugbank":["DB13106"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297321","canonicalSmiles":"CS(=O)(=O)OCCN(CCBr)c1c(C(=O)NCCOP(=O)(O)O)cc([N+](=O)[O-])cc1[N+](=O)[O-]","inchiKey":"GZSOKPMDWVRVMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PR-104","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pr 104","Pr-104"],"crossReferences":{"drugbank":["DB05968"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297327","canonicalSmiles":"COCCCN1CCC(c2nnc(-c3nn(C(C)C)c4ccccc34)o2)CC1","inchiKey":"DWTFBJGTRBMHPG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUVN-D4010","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Suvn-d4010"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297356","canonicalSmiles":"CCCCOc1nc(N)c2[nH]c(=O)n(CCCN(CCCN3CCOCC3)Cc3cccc(CC(=O)OC)c3)c2n1","inchiKey":"FEFIBEHSXLKJGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-8848","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD8848","Azd 8848","Azd-8848","Azd8848","DSP-3025","Dsp-3025"],"crossReferences":{"drugbank":["DB14868"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297366","canonicalSmiles":"CN(C)CCCNC(=O)/C(=C/CCCCC(=O)NO)COc1cccc2ccccc12","inchiKey":"AUGCSOFQTDKPSO-RGVLZGJSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CG-200745","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CG 2 (HDAC INHIBITOR)","CG-2","CG-200745","CG200745","Cg-200745","Cg200745","HDCG-0745","Ivaltinostat","J3.106.463E"],"crossReferences":{"drugbank":["DB12259"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297430","canonicalSmiles":"CN(C)C(=O)N1C[C@H]2C[C@](C)(NCC(=O)N3C[C@@H](F)C[C@H]3C#N)C[C@H]2C1.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"VBMNNLBIPDGFBS-XGXURLCGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BESIGLIPTIN TOSYLATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4300558","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Besigliptin tosylate","SHR117887","Shr117887"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297599","canonicalSmiles":"N[C@@H](CC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1)C(=O)O","inchiKey":"PVPJTBAEAQVTPN-HRAQMCAYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASPACYTARABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aspacytarabine","BST-236","Bst-236"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297764","drugType":"Unknown","blackBoxWarning":false,"name":"HETROMBOPAG OLAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hetrombopag olamine","SHR-8735 OLAMINE","SHR8735 OLAMINE"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297872","drugType":"Unknown","blackBoxWarning":false,"name":"EPRATUZUMAB-CYS-TESIRINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADCT-602","Adct-602","Epratuzumab-cys-tesirine","HLL2-TESIRINE"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297998","drugType":"Antibody","blackBoxWarning":false,"name":"LACUTAMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IPH-4102","IPH4102","Iph4102","Lacutamab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL442","canonicalSmiles":"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21","inchiKey":"XCGSFFUVFURLIX-VFGNJEKYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ERGOTAMINE","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ergotamine","Ergotamine Tartrate","NSC-95090"],"crossReferences":{"DailyMed":["ergotamine%20tartrate"],"Wikipedia":["Ergotamine"],"drugbank":["DB00696"],"chEBI":["64318"]},"childChemblIds":["CHEMBL2448612","CHEMBL1743258","CHEMBL2131781"],"count":2,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000179546","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":7},"linkedDiseases":{"rows":["EFO_0003821","EFO_0005252"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1948 and is indicated for migraine disorder and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4594258","canonicalSmiles":"CCCC[C@](C)(CO)Nc1nc(N)nc2cc(F)cnc12","inchiKey":"HTCJUBZBSJQWBW-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELGANTOLIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-9688","Gs-9688","Selgantolimod"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594412","canonicalSmiles":"CN1C(=O)C(C)(C)Oc2c(-c3cn(C)c(=O)c4[nH]ccc34)cc(S(C)(=O)=O)cc21","inchiKey":"VZSAMEOETVNDQH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INCB-057643","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INCB057643","Incb-057643","Incb057643"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594445","canonicalSmiles":"CNCc1cn(S(=O)(=O)c2cccc(F)c2)c(-c2ccc(F)cc2F)c1OC","inchiKey":"OUNXGNDVWVPCOL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABEPRAZAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abeprazan","DWP-14012","DWP14012","Dwp14012","Fexuprazan"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594485","drugType":"Unknown","blackBoxWarning":false,"name":"OLAPTESED PEGOL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NOX-A12 FREE ACID","Olaptesed pegol"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594496","drugType":"Unknown","blackBoxWarning":false,"name":"SEA-BCMA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sea-bcma"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594559","drugType":"Unknown","blackBoxWarning":false,"name":"INCAGN-02385","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INCAGN-02385","INCAGN02385","Incagn-02385","Incagn02385"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594570","drugType":"Unknown","blackBoxWarning":false,"name":"LHC-165","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LHC-165","LHC165","Lhc-165","Lhc165"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL46399","canonicalSmiles":"CC1C2Cc3ccc(O)cc3C1(C)CCN2CCc1ccccc1","inchiKey":"ZQHYKVKNPWDQSL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENAZOCINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Phenazocine"],"crossReferences":{"Wikipedia":["Phenazocine"]},"childChemblIds":["CHEMBL2107297"],"count":1,"approvedIndications":["EFO_0003843"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for pain."}
{"id":"CHEMBL46780","canonicalSmiles":"Cn1c(Cc2ccc(C(=N)N)cc2)nc2cc(NS(=O)(=O)c3ccccc3)ccc21","inchiKey":"MEUAVGJWGDPTLF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL46780","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07508"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL47181","canonicalSmiles":"O=C(O)COP(=O)(O)O","inchiKey":"ASCFNMCAHFUBCO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHOGLYCOLIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Phosphoglycolatephosphonooxy-Acetic Acid","Phosphonooxy-Acetic Acid Anion"],"crossReferences":{"drugbank":["DB02726"],"chEBI":["17150"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL49004","canonicalSmiles":"COC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CC[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(C)C)C(C)C","inchiKey":"IUDCAKKZLXFOQA-QJAPXLAMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL49004","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04191"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL506110","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)OCOC(=O)[C@@H]1N2C(=O)C[C@H]2S(=O)(=O)C1(C)C","inchiKey":"OPYGFNJSCUDTBT-PMLPCWDUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULTAMICILLIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Unasyn"],"synonyms":["CP-49,952","CP-49952","Sultamicillin","Sultamicillin tosilate","VD-1827"],"crossReferences":{"Wikipedia":["Sultamicillin"],"drugbank":["DB12127"],"chEBI":["51770"]},"childChemblIds":["CHEMBL3183856"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL510095","canonicalSmiles":"CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)C[C@]12C","inchiKey":"PWAOOJDMFUQOKB-WCZZMFLVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GINSENOSIDE RE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ginsenoside re","NSC-308877"],"crossReferences":{"drugbank":["DB14815"],"chEBI":["77148"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL521078","canonicalSmiles":"CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@H]1[C@@H]2N1C","inchiKey":"HRHKSTOGXBBQCB-VFWICMBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PORFIROMYCIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-methylmitomycin c","NSC-56410","Porfiromycin","U-14,743","U-14743"],"crossReferences":{"drugbank":["DB06478"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL524004","canonicalSmiles":"C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1","inchiKey":"GKNPSSNBBWDAGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPENZOLATE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Mepenzolate"],"crossReferences":{"Wikipedia":["Mepenzolate"],"drugbank":["DB04843"]},"childChemblIds":["CHEMBL1724"],"count":1,"approvedIndications":["EFO_0010282"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL540070","canonicalSmiles":"Br.COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12","inchiKey":"ORNYSFFJCBCUPL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL540070","maximumClinicalTrialPhase":0,"parentId":"CHEMBL43","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL546","canonicalSmiles":"C=CCOc1ccccc1OCC(O)CNC(C)C","inchiKey":"CEMAWMOMDPGJMB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXPRENOLOL","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Oxprenolol"],"crossReferences":{"Wikipedia":["Oxprenolol"],"drugbank":["DB01580"]},"childChemblIds":["CHEMBL1200745","CHEMBL3245937"],"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983 and is indicated for cardiovascular disease."}
{"id":"CHEMBL552425","canonicalSmiles":"Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1cncc(C(N)=O)c1","inchiKey":"SAAYRHKJHDIDPH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL552425","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07970"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL57997","canonicalSmiles":"Nc1sc2c(c1C(=O)c1ccc(Cl)cc1)CCCC2","inchiKey":"OTZVBZFYMFTYKH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL57997","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217669"],"drugbank":["DB12919"]},"childChemblIds":["CHEMBL203347"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL590985","canonicalSmiles":"Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCCNC(=O)c4ccccc4C(=O)O)C(=O)O)cc3)cnc2n1","inchiKey":"NYQPLPNEESYGNO-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALOTREXIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-623017","Talotrexin"],"crossReferences":{"drugbank":["DB06178"]},"childChemblIds":["CHEMBL2104985"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL603469","canonicalSmiles":"C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O","inchiKey":"UIARLYUEJFELEN-LROUJFHJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LESTAURTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-154475","A-154475.0","CEP-701","Cep-701","KT-555","KT-5555","KT5555","Lestaurtinib","SP-924","SP924","SPM-924"],"crossReferences":{"PubChem":["144206186","50113274"],"Wikipedia":["Lestaurtinib"]},"count":9,"linkedTargets":{"rows":["ENSG00000096968","ENSG00000165731","ENSG00000140538","ENSG00000148053","ENSG00000122025","ENSG00000198400"],"count":6},"linkedDiseases":{"rows":["EFO_0000565","MONDO_0044903","EFO_0000676","EFO_0000222","EFO_1001947","EFO_0001378","EFO_0002429","EFO_0000621","MONDO_0008315","EFO_0000479"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL65433","canonicalSmiles":"O=C(NCNC(=O)NC1C(=O)NC(=O)N1CO)NC1C(=O)NC(=O)N1CO","inchiKey":"ZCTXEAQXZGPWFG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMIDUREA","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imidurea"],"crossReferences":{"PubChem":["144212642","56463555"],"Wikipedia":["Imidazolidinyl_urea"],"drugbank":["DB14075"],"chEBI":["51805"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL658","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1","inchiKey":"GGCSSNBKKAUURC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SUFENTANIL","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["IDS-NS-001","R 30,730","R-30730","Sufentanil"],"crossReferences":{"DailyMed":["sufentanil%20citrate"],"Wikipedia":["Sufentanil"],"drugbank":["DB00708"],"chEBI":["9316"]},"childChemblIds":["CHEMBL1201163"],"count":7,"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0000546","EFO_1001139","EFO_1001219","HP_0012532","EFO_0005323","EFO_1000652","EFO_0000432","EFO_0009267","HP_0003418","EFO_0000266","EFO_0003843","EFO_0002950"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL73451","canonicalSmiles":"c1ccc2c(c1)Sc1ccccc1N2CC1CN2CCC1CC2","inchiKey":"HOKDBMAJZXIPGC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEQUITAZINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Primalan"],"synonyms":["Mequitazine"],"crossReferences":{"PubChem":["144207197","170465794","26665232","453325","56320321"],"drugbank":["DB01071"],"chEBI":["31821"]},"count":1,"approvedIndications":["EFO_0003785"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for allergy."}
{"id":"CHEMBL74371","canonicalSmiles":"c1c[nH]c(Nc2ccc(Nc3ccc(Nc4ncc[nH]4)cc3)cc2)n1","inchiKey":"JHMXUERQMCJRHG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL74371","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08331"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL76688","canonicalSmiles":"CC(C)(C)C(=O)Oc1ccc(S(=O)(=O)Nc2ccccc2C(=O)NCC(=O)O)cc1","inchiKey":"BTGNGJJLZOIYID-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIVELESTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-544349","LY544349","ONO-5046","Sivelestat"],"crossReferences":{"Wikipedia":["Sivelestat"],"drugbank":["DB12863"]},"childChemblIds":["CHEMBL3182314","CHEMBL2107493"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL79280","canonicalSmiles":"COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1F","inchiKey":"ROZCIVXTLACYNY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BATABULIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Batabulin","T-138067","T-67","T138067","T67","TL 057","TL-057"],"childChemblIds":["CHEMBL2105902","CHEMBL22724"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL82293","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)O","inchiKey":"IPCSVZSSVZVIGE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALMITIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Palmitic acid"],"crossReferences":{"PubChem":["144205658","144208869","144213283","170465588","26757777"],"Wikipedia":["Palmitic_acid"],"drugbank":["DB03796"],"chEBI":["15756"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL929","canonicalSmiles":"CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1.CS(=O)(=O)O","inchiKey":"MEPNHSOMXMALDZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELAVIRDINE MESYLATE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL593","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rescriptor"],"synonyms":["Delavirdine mesilate","Delavirdine mesylate","Delavirdine methanesulfonate","Rescriptor","U-90152S","U-90152T"],"crossReferences":{"chEBI":["4379"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997 and has 1 investigational indication."}
{"id":"CHEMBL93687","canonicalSmiles":"O=C(CC1(S(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1)NO","inchiKey":"QOPFTBAEAJQKSY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL93687","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02049"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL94","canonicalSmiles":"CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C","inchiKey":"PIJVFDBKTWXHHD-HIFRSBDPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHYSOSTIGMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Eserine","MCV-4484","NSC-30782","Physostigmine"],"crossReferences":{"PubChem":["144204779","144211908","170465757","26753571","26753572","50085948","50106262","50106263","90340907"],"Wikipedia":["Physostigmine"],"drugbank":["DB00981"],"chEBI":["27953"]},"childChemblIds":["CHEMBL338975","CHEMBL537674","CHEMBL2105891"],"count":4,"approvedIndications":["EFO_0000516"],"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["EFO_0002614","EFO_0009267","EFO_0000516","EFO_0003843"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for glaucoma and has 3 investigational indications."}
{"id":"CHEMBL95889","canonicalSmiles":"C[N+](C)(C)CC(=O)O","inchiKey":"KWIUHFFTVRNATP-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cystadane"],"synonyms":["Betaine","Betaine, anhydrous","Cystadane","FEMA NO. 4223","NSC-166511"],"crossReferences":{"DailyMed":["betaine"],"PubChem":["11110845","174007375","90341438"],"drugbank":["DB04455"],"chEBI":["41139"]},"childChemblIds":["CHEMBL1201130"],"count":8,"approvedIndications":["EFO_0003761","MONDO_0004737"],"linkedTargets":{"rows":["ENSG00000132840","ENSG00000145692"],"count":2},"linkedDiseases":{"rows":["EFO_0004248","Orphanet_416","EFO_0004220","EFO_1001249","EFO_0003761","EFO_0003047","EFO_0001073","MONDO_0004737"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for homocystinuria (disease) and unipolar depression and has 6 investigational indications."}
{"id":"CHEMBL963","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5","inchiKey":"UQCNKQCJZOAFTQ-ISWURRPUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OXYMORPHONE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["IDS-NO-003","NIH 10323","NSC-19045","Numorphan","Opana","Oxycodone hydrochloride impurity, oxymorphone-","Oxymorphone","Oxymorphone cii"],"crossReferences":{"DailyMed":["oxymorphone%20hydrochloride"],"Wikipedia":["Oxymorphone"],"drugbank":["DB01192"],"chEBI":["7865"]},"childChemblIds":["CHEMBL1200794"],"count":2,"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["HP_0012532","EFO_0005611","EFO_0003843","EFO_0007490"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL97355","canonicalSmiles":"COc1nccnc1CC(C)C","inchiKey":"UXFSPRAGHGMRSQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL97355","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04512"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL99447","canonicalSmiles":"O=C(O)c1ccc2cc(C(F)(F)P(=O)(O)O)ccc2c1","inchiKey":"NKGNOWNPXBURRW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL99447","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08397"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
